In fact, other PDE family members, such as PDE3, 4 (see above) and 5, have already been implicated in CFTR regulation and the use of PDE inhibitors has already been proposed as a potential therapy for CF (Turner et al., 2021). This evidence concerns the gene CFTR and cystic fibrosis.